| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.005 |